Aptamer Sciences Inc (KOSDAQ: 291650)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,138.00
-302.00 (-20.97%)
Dec 20, 2024, 9:00 AM KST

Aptamer Sciences Company Description

Aptamer Sciences Inc, a bio venture company, focuses on the Aptamer technology platform for the development of therapeutic and diagnostic platforms.

The company’s platforms include aptamer discovery, optimization, and the development of therapeutics and diagnostics for cancer and neurological disorders.

It offers AlloMAp and Bi-Functional Aptame (BiFAp) platform programs for therapeutics, as well as Aptodetect-lung, an early diagnosis kit for lung cancer.

Aptamer Sciences Inc was founded in 2011 and is headquartered in Seongnam-si, South Korea.

Aptamer Sciences Inc
Country South Korea
Founded 2011
Industry Biological Products, Except Diagnostic Substances
CEO Dongil Han

Contact Details

Address:
3-301, (Sampyeong-dong Pangyo seven venture Valley1)
Seongnam-si, 13487
South Korea
Phone 82-31-786-0317
Website aptsci.com

Stock Details

Ticker Symbol 291650
Exchange KOSDAQ
Fiscal Year January - December
Reporting Currency KRW
SIC Code 2836

Key Executives

Name Position
Dongil Han Chief Executive Officer
CheolHwan Lee Chief Financial Officer